NASDAQ: OLKOlink Holding Ab Stock
$22.43+0.23 (+1.04%)
Updated Apr 24, 2024
OLK Price
$22.43
Fair Value Price
N/A
Market Cap
$2.79B
52 Week Low
$14.10
52 Week High
$26.01
P/E
-89.72x
P/B
5.55x
P/S
18.44x
PEG
N/A
Dividend Yield
N/A
Revenue
$169.60M
Earnings
-$31.60M
Gross Margin
67.5%
Operating Margin
-23.02%
Profit Margin
-18.6%
Debt to Equity
0.2
Operating Cash Flow
-$30M
Beta
1.52
Next Earnings
May 9, 2024
Ex-Dividend
N/A
Next Dividend
N/A
OLK Overview
Olink Holding AB (publ) offers life science research products and services. Offerings include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases, Olink Focus, custom developed solutions for customers that have identified proteins of interest, and Olink Signature Q100, a qPCR readout platform. Olink Holding was founded in 2004 and is headquartered in Uppsala, Sweden.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how OLK scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
OLK is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
OLK is poor value based on its book value relative to its share price (5.55x), compared to the US Diagnostics & Research industry average (4.22x)
P/B vs Industry Valuation
OLK is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more OLK due diligence checks available for Premium users.
Be the first to know about important OLK news, forecast changes, insider trades & much more!
OLK News
Valuation
OLK price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-89.72x
Industry
38.76x
Market
41.27x
OLK price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.55x
Industry
4.22x
OLK is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
OLK's financial health
Profit margin
Revenue
$68.6M
Net Income
-$7.5M
Profit Margin
-11%
OLK's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
OLK's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$602.3M
Liabilities
$99.6M
Debt to equity
0.2
OLK's short-term assets ($263.47M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OLK's short-term assets ($263.47M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OLK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.9M
Investing
-$9.5M
Financing
-$754.0k
OLK's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
OLK vs Diagnostic & Research Stocks
Olink Holding Ab Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.